CLOBETASONE: 313 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
313
Total FAERS Reports
0
Deaths Reported
80
Hospitalizations
313
As Primary/Secondary Suspect
30
Life-Threatening
190
Disabilities
Active Ingredient: CLOBETASONE BUTYRATE ·
First Report: 199801 · Latest Report: 20250319
What Are the Most Common CLOBETASONE Side Effects?
#1 Most Reported
Skin exfoliation
154 reports (49.2%)
#2 Most Reported
Erythema
144 reports (46.0%)
#3 Most Reported
Skin weeping
129 reports (41.2%)
All CLOBETASONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Skin exfoliation | 154 | 49.2% | 0 | 51 |
| Erythema | 144 | 46.0% | 0 | 41 |
| Insomnia | 129 | 41.2% | 0 | 52 |
| Skin weeping | 129 | 41.2% | 0 | 39 |
| Pruritus | 120 | 38.3% | 0 | 35 |
| Skin burning sensation | 116 | 37.1% | 0 | 36 |
| Steroid withdrawal syndrome | 104 | 33.2% | 0 | 21 |
| Medication error | 81 | 25.9% | 0 | 25 |
| Alopecia | 74 | 23.6% | 0 | 18 |
| Neuralgia | 59 | 18.9% | 0 | 22 |
| Dry skin | 55 | 17.6% | 0 | 24 |
| Skin atrophy | 53 | 16.9% | 0 | 14 |
| Fatigue | 51 | 16.3% | 0 | 18 |
| Topical steroid withdrawal reaction | 50 | 16.0% | 0 | 13 |
| Lymphadenopathy | 46 | 14.7% | 0 | 4 |
| Rash | 43 | 13.7% | 0 | 18 |
| Temperature regulation disorder | 42 | 13.4% | 0 | 10 |
| Skin wrinkling | 39 | 12.5% | 0 | 12 |
| Pain | 37 | 11.8% | 0 | 16 |
| Skin infection | 36 | 11.5% | 0 | 16 |
Who Reports CLOBETASONE Side Effects? Age & Gender Data
Gender: 85.8% female, 14.2% male. Average age: 29.9 years. Most reports from: GB. View detailed demographics →
Is CLOBETASONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 0 |
| 2006 | 3 | 0 | 3 |
| 2008 | 6 | 0 | 0 |
| 2010 | 10 | 0 | 5 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 6 | 0 | 2 |
| 2015 | 10 | 0 | 0 |
| 2016 | 3 | 0 | 2 |
| 2017 | 15 | 0 | 2 |
| 2018 | 39 | 0 | 7 |
| 2019 | 9 | 0 | 3 |
| 2020 | 40 | 0 | 3 |
| 2021 | 45 | 0 | 8 |
| 2022 | 14 | 0 | 8 |
| 2023 | 10 | 0 | 5 |
| 2024 | 3 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
What Is CLOBETASONE Used For?
| Indication | Reports |
|---|---|
| Eczema | 187 |
| Product used for unknown indication | 37 |
| Dermatitis atopic | 21 |
| Pemphigoid | 16 |
| Ill-defined disorder | 10 |
CLOBETASONE vs Alternatives: Which Is Safer?
CLOBETASONE vs CLODRONATE
CLOBETASONE vs CLOFARABINE
CLOBETASONE vs CLOFAZIMINE
CLOBETASONE vs CLOMETHIAZOLE
CLOBETASONE vs CLOMIPHENE
CLOBETASONE vs CLOMIPRAMINE
CLOBETASONE vs CLONAZEPAM
CLOBETASONE vs CLONIDINE
CLOBETASONE vs CLOPIDOGREL
CLOBETASONE vs CLOPIDOGREL BESILATE
Official FDA Label for CLOBETASONE
Official prescribing information from the FDA-approved drug label.